Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Listening to silence and understanding nonsense: exonic mutations that affect splicing
20021.7k citationsLuca Cartegni, Shern L. Chew et al.profile →
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
2012916 citationsRyszard Kole, Adrian R. Krainer et al.Nature Reviews Drug Discoveryprofile →
The human splicing code reveals new insights into the genetic determinants of disease
2014829 citationsHui Xiong, Babak Alipanahi et al.Scienceprofile →
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
2007720 citationsRotem Karni, Adrian R. Krainer et al.Nature Structural & Molecular Biologyprofile →
Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro
1984671 citationsAdrian R. Krainer et al.profile →
CRISPR Inversion of CTCF Sites Alters Genome Topology and Enhancer/Promoter Function
2015648 citationsAdrian R. Krainer et al.profile →
Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2
1992642 citationsAkila Mayeda, Adrian R. Krainerprofile →
Normal and mutant human β-globin pre-mRNAs are faithfully and efficiently spliced in vitro
1984615 citationsAdrian R. Krainer et al.profile →
Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1
2002578 citationsLuca Cartegni, Adrian R. Krainerprofile →
Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
2011556 citationsYimin Hua, Kentaro Sahashi et al.Natureprofile →
Regulation of Alternative Splicing in Vivo by Overexpression of Antagonistic Splicing Factors
1994536 citationsJavier F. Cáceres, Adrian R. Krainer et al.Scienceprofile →
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
2010501 citationsYimin Hua, Kentaro Sahashi et al.Genes & Developmentprofile →
Antisense Oligonucleotide Therapies for Neurodegenerative Diseases
2019242 citationsC. Frank Bennett, Adrian R. Krainer et al.Annual Review of Neuroscienceprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Adrian R. Krainer
Since
Specialization
Citations
This map shows the geographic impact of Adrian R. Krainer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian R. Krainer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian R. Krainer more than expected).
Fields of papers citing papers by Adrian R. Krainer
This network shows the impact of papers produced by Adrian R. Krainer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian R. Krainer. The network helps show where Adrian R. Krainer may publish in the future.
Co-authorship network of co-authors of Adrian R. Krainer
This figure shows the co-authorship network connecting the top 25 collaborators of Adrian R. Krainer.
A scholar is included among the top collaborators of Adrian R. Krainer based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Adrian R. Krainer. Adrian R. Krainer is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Bennett, C. Frank, Adrian R. Krainer, & Don W. Cleveland. (2019). Antisense Oligonucleotide Therapies for Neurodegenerative Diseases. Annual Review of Neuroscience. 42(1). 385–406.242 indexed citations breakdown →
Xiong, Hui, Babak Alipanahi, Leo J. Lee, et al.. (2014). The human splicing code reveals new insights into the genetic determinants of disease. Science. 347(6218). 1254806–1254806.829 indexed citations breakdown →
6.
Kole, Ryszard, Adrian R. Krainer, & Sidney Altman. (2012). RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nature Reviews Drug Discovery. 11(2). 125–140.916 indexed citations breakdown →
Hua, Yimin, Kentaro Sahashi, Frank Rigo, et al.. (2011). Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature. 478(7367). 123–126.556 indexed citations breakdown →
Zhang, Chaolin, Zuo‐Feng Zhang, John C. Castle, et al.. (2008). Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2 (Genes and Development (2008) 22 (2550-2563)). Genes & Development. 22(20).46 indexed citations
13.
Khoo, Bernard, Xavier Roca, Shern L. Chew, & Adrian R. Krainer. (2007). Antisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB. Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory).5 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.